Deal History
Om oss
Om oss
Team
Våra kontor
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Skuldrådgivning
Equity Research
Tillväxtkapital
IPO Advisory
Industries
Företagstjänster
Internet och konsumentprodukter
Industri och verkstad
Sjuk- och hälsovård
Mjukvara och TMT
Research
Analysmaterial
Makro och marknad
Career
Events
Insights
News
Bolagsnyheter
Deal News
I pressen
Newsletter
Kontakt
Newsletter
SV
INT
DA
DE
FR
US
Main menu button
Team
Deals
Kontakt
Aktieanalys
Team
Deals
Kontakt
Nyheter
Alla
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Alzinova
Angler Gaming
Arctic Minerals
BellPal Holding
Bentley Endovascular Group
Biosergen
Biovica
Boozt
Candles Scandinavia
Cantargia
Carlsquare
CDON
CellaVision
CombiGene
CSAM Health Group
DanCann Pharma
Ecoclime
edyoutec
Elicera Therapeutics
Enrad
Fable Media
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
Gubra
H&D Wireless
Hansa Biopharma
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Lokotech
Medclair Invest
Medivir
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nexam Chemical
Nischer Properties
Nodebis
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Prolight Diagnostics
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Alla
Analysmaterial
Bolagsnyheter
Deal News
Events
I pressen
Insights
Makro och marknad
02 apr 2025
Equity Research Nosa Plugs: Cash flow in the black, goal achieved
Analysmaterial
Nosa Plugs
20 feb 2025
Equity research Nosa Plugs Q4, 2024: Strong growth and announced M&A strategy
Analysmaterial
Nosa Plugs
14 feb 2025
Equity Research Nosa Plugs: First impression Q4, 2024
Analysmaterial
Nosa Plugs
19 dec 2024
Equity Research Nosa Plugs: Drug Delivery patent submitted
Analysmaterial
Nosa Plugs
19 nov 2024
Equity research Nosa Plugs Q3, 2024: Strong growth with a rise in valuation on the cards
Analysmaterial
Nosa Plugs
08 nov 2024
Equity Research Nosa Plugs: First impression Q3, 2024
Analysmaterial
Nosa Plugs
29 aug 2024
Equity research Nosa Plugs Q2, 2024: A second quarter with significant news flow
Analysmaterial
Nosa Plugs
23 aug 2024
Equity Research Nosa Plugs: First impression Q2, 2024
Analysmaterial
Nosa Plugs
20 jun 2024
Equity Research Nosa Plugs: New orders and distributor agreements
Analysmaterial
Nosa Plugs
17 maj 2024
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
Analysmaterial
Nosa Plugs
21 feb 2024
Analys Nosa Plugs kv4, 2023: Nytt försäljningsrekord stöttar forskning och utveckling
Analysmaterial
Nosa Plugs
16 feb 2024
Equity Research Nosa Plugs: First impression Q4, 2023
Analysmaterial
Nosa Plugs
06 feb 2024
Analys Nosa Plugs: drug delivery tar ett stort första steg
Analysmaterial
Nosa Plugs
06 feb 2024
Equity Research Nosa Plugs: drug delivery taking a big first step
Analysmaterial
Nosa Plugs
06 feb 2024
Carlsquare Equity Research intervju med Nosa Plugs
Analysmaterial
Nosa Plugs
11 dec 2023
Analys Nosa Plugs: riktade nyemissioner för att satsa på Nosa Drug delivery
Analysmaterial
Nosa Plugs
08 dec 2023
Nosa Plugs at Carlsquare Nordic life science investor day
Analysmaterial
Nosa Plugs
16 nov 2023
Analys Nosa Plugs: Lansering snabbare än förväntat
Analysmaterial
Nosa Plugs
10 nov 2023
Equity Research Nosa Plugs: First impression Q3, 2023
Analysmaterial
Nosa Plugs
22 sep 2023
Carlsquare Equity Research: Nordic Life Science sector update
Analysmaterial
Kancera
1
2